Blueprint Medicines Corp (FRA:2L9)
€ 97.46 1.76 (1.84%) Market Cap: 5.95 Bil Enterprise Value: 5.66 Bil PE Ratio: 0 PB Ratio: 20.71 GF Score: 68/100

Blueprint Medicines Corp (FRA:2L9) Transcripts

  • 1